advertisement
Abstract #90728 Published in IGR 21-3
Detection of serum uric acid in primary open angle glaucoma: A pilot study
Serra R; Coscas F; Pinna A; Peri M; Zucca I; Sellam A; Sellam A; Giancipoli E; Boscia FEuropean Journal of Ophthalmology 2020; 0: 1120672120944012
PURPOSE: To assess the association between the serum levels of uric acid (UA) and primary open-angle glaucoma (POAG). METHODS: In this pilot study, 46 eyes of 23 patients with a clinical history of POAG and 30 eyes of 15 healthy subjects were included. All patients underwent a complete ophthalmological examination, including best corrected visual acuity (BCVA), intraocular pressure (IOP), and gonioscopy. Visual field parameters, such as mean deviation (MD) and pattern standard deviation (PSD), and optical coherence tomography (OCT) values of the optic nerve head, including retinal nerve fiber layer (RNFL) thickness and vertical cup/disc ratio (VCDR), were noted. A blood sample was collected from each subject for serum UA measurement. RESULTS: IOP, MD, PSD, RNFL thickness, and VCDR resulted significantly different in POAG patients, when compared with controls ( < 0.05). POAG patients showed significantly lower levels of mean serum UA than healthy controls (4.00 ± 0.66 mg/dL vs 4.95 ± 0.86 mg/dL, respectively, < 0.0001). Furthermore, severe POAG patients showed mean serum levels of UA lower than mild POAG patients (3.36 ± 0.70 mg/dL vs 4.22 ± 0.51 mg/dL, respectively, = 0.01). Visual field and OCT parameters were statistically correlated with the mean serum levels of UA in POAG eyes ( < 0.05). CONCLUSION: Results suggest that in POAG patients, serum UA levels may be decreased and correlated with visual field and OCT parameters worsening. Further larger multi-center prospective studies are necessary to confirm our findings and establish the role of UA in glaucoma.
Full article
Classification:
9.4.15 Glaucoma in relation to systemic disease (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders)
3.7 Biochemistry (Part of: 3 Laboratory methods)
13.1 Prognostic factors (Part of: 13 Therapeutic prognosis and outcome)
